Home › NDC Lookup › RxCUI directory › RxCUI 310992

Indomethacin 75 MG Extended Release Oral Capsule — RxCUI 310992

Name: Indomethacin 75 MG Extended Release Oral Capsule (RxCUI 310992)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 310992 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 65 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310992

Official nameIndomethacin 75 MG Extended Release Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped16

Package NDCs mapped65

Reported Medicaid activity (SDUD)5,455 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Indomethacin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Indocin suppositories treat the same conditions as indomethacin capsules — things like rheumatoid arthritis flares, gout attacks, painful shoulder, and ankylosing spondylitis. The...
What exactly is this suppository treating, and why can't I just take a pill?
Insert the suppository rectally as directed, and — this is the most important part — try to hold it in for at least one hour. The suppository dissolves quickly, so if you don't ret...
How do I use it correctly? I want to make sure I'm doing it right.

📖 Read our full Indomethacin Rectal guide →

🕸️ Concept Web — How Indomethacin 75 MG Extended Release Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Indomethacin 75 MG Extended Release Oral Capsule RxCUI 310992 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Indomethacin 5781 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Indomethacin Extended Release Oral Capsule 370689 SCDF
- Indomethacin Oral Product 1156905 SCDG
- Indomethacin Pill 1156906 SCDG
- Extended Release Oral Capsule 316943 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Indomethacin 75 MG 316085 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Indomethacin 75 MG SCDC · 316085
Indomethacin Extended Release Oral Capsule SCDF · 370689
Indomethacin Oral Product SCDG · 1156905
Indomethacin Pill SCDG · 1156906

📦 FDA Products & Package NDCs

16 products · 65 package NDCs

65 package NDCs map to RxCUI 310992 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
76420-0029-01	1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-01)	Indomethacin	Asclemed USA, Inc.	2020-02-11
76420-0029-02	2 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-02)	Indomethacin	Asclemed USA, Inc.	2020-02-11
76420-0029-07	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-07)	Indomethacin	Asclemed USA, Inc.	2020-02-11
76420-0029-14	14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-14)	Indomethacin	Asclemed USA, Inc.	2020-02-11
80425-0271-01	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (80425-0271-1)	Indomethacin ER	Advanced Rx Pharmacy of Tennessee, LLC	2023-02-17
85766-0034-00	10 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-00)	Indomethacin	Sportpharm LLC	2026-04-03
85766-0034-01	1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-01)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-02	2 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-02)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-07	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-07)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-10	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-10)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-14	14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-14)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-20	20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-20)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-30	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-30)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-60	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-60)	Indomethacin	Sportpharm LLC	2025-08-07
85766-0034-90	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-90)	Indomethacin	Sportpharm LLC	2025-08-07

Observed labelers: Bryant Ranch Prepack (20) · Sportpharm LLC (10) · Amneal Pharmaceuticals LLC (6) · KVK-Tech, Inc. (6) · Camber Pharmaceuticals, Inc. (5) · Glenmark Pharmaceuticals Inc., USA (5) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.2121

Range $0.2121–$0.2230 · middle 50% $0.2121–$0.2203 · 10 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.